Identifications of hordeolum pathogens and its susceptibility to antimicrobial agents in topical and oral medications

1. Albert DM, Jakobiec FA. Principles and Practice of Ophthalmology: WB Saunders Company, 2000.Search in Google Scholar

2. Diegel JT. Eyelid problems. Blepharitis, hordeola, and chalazia. Postgraduate medicine. 1986; 80:271-2.10.1080/00325481.1986.11699502Open DOISearch in Google Scholar

3. Hirunwiwatkul P, Wachirasereechai K. Effectiveness of combined antibiotic ophthalmic solution in the treatment of hordeolum after incision and curettage: a randomized, placebo-controlled trial: a pilot study. J Med Assoc Thai. 2005; 88:647-50.Search in Google Scholar

4. Lederman C, Miller M. Hordeola and chalazia. Pediatr Rev. 1999; 20:283-4.10.1542/pir.20-8-283Open DOISearch in Google Scholar

5. Mueller JB, McStay CM. Ocular infection and inflammation. Emerg Med Clin North Am. 2008; 26: 57-7210.1016/j.emc.2007.10.004Open DOISearch in Google Scholar

6. Wilkie JL. Styes. The Practitioner.1956; 176:318-21.Search in Google Scholar

7. Panicharoen C, Hirunwiwatkul P. Current treatment of hordeolum by ophthalmologist in Thailand. J Med Assoc Thai. 2011; 94:721-4.Search in Google Scholar

8. Fraunfelder F, Hordeolum, Fraunfelder FT, Roy FH. Current ocular therapy. 4th ed. Philadelphia: Saunders. 1995:578-9.Search in Google Scholar

9. Moreira BM, Daum RS. Antimicrobial resistance in staphylococci. Pediatr Clin North Am. 1995; 42:619-48.10.1016/S0031-3955(16)38982-9Open DOISearch in Google Scholar

10. Lin B, Su X. The clinical observation of China-made ofloxacin eye drops in the treatment of bacterial infection of the external eye. Yan Ke Xue Bao. 1994; 10:251-3.Search in Google Scholar

11. Gaynor BD, Chidambaram JD, Cevallos V, Miao Y, Miller K, Jha HC, et al. Topical ocular antibiotics induce bacterial resistance at extraocular sites. Br. J. Ophthalmol. 2005; 89:1097-9.Search in Google Scholar

12. Hwang DG. Fluoroquinoline resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones. Surv Ophthalmol. 2004; 49 (Suppl 2):S79-83.10.1016/j.survophthal.2004.01.004Open DOISearch in Google Scholar

13. Bal AM, Gould IM. Antibiotic resistance in Staphylococcus aureus and its relevance in therapy. Expert Opinion on Pharmacotherapy. 2005; 6:2257-69.10.1517/14656566.6.13.2257Open DOISearch in Google Scholar

14. Kirby WMM. Extraction of a highly potent penicillin inactivator from penicillin resistant staphylococci. Science. 1944; 99:452.10.1126/science.99.2579.452Open DOISearch in Google Scholar

15. Thornsberry C. The development of antimicrobial resistance in staphylococci. J Antimicrob Chemother. 1998; 21 Suppl C:9-17.Search in Google Scholar

16. Barber M. Methicillin-resistant staphylococci. J Clin Pathol. 1961; 14:385.10.1136/jcp.14.4.385Open DOISearch in Google Scholar

17. Jevons MP. “Celbenin”-resistant staphylococci. Br Med J. 1961; 1:124.10.1136/bmj.1.5219.124-aOpen DOISearch in Google Scholar

18. Maranan M.C., Moreira B., and Boyle-Vavra S. et al. Antimicrobial Resistance in Staphylococci. Infectious Disease Clinics of North America. 1997; 11:813-49.10.1016/S0891-5520(05)70392-5Open DOISearch in Google Scholar

19. Titcomb L.C. Eye Disorders Topical ocular antibiotics: part 2. The Pharmaceutical Journal. 2000; 264 :441-5.Search in Google Scholar

20. Donnenfeld ED, Schrier A, Perry HD, Aulicino T, Gombert ME, Snyder R. Penetration of topically applied ciprofloxacin, norfloxacin and ofloxacin into the aqueous humor. Ophthalmology. 1994; 101:902-5.10.1016/S0161-6420(13)31248-2Open DOISearch in Google Scholar

21. Cekiç O, Batman C, Totan Y, Yasar U, Basci NE, Bozkurt A, et al. Aqueous humour levels of topically applied ciprofloxacin and ofloxacin in the same subjects. Eye. 1999; 13:656-9.10.1038/eye.1999.178Open DOISearch in Google Scholar

22. Borrmann L, Tang-Liu DD, Kann J, Nista J, Lin ET, Frank J. Ofloxacin in human serum, urine and tear film following topical application. Cornea. 1992; 11: 226-30.10.1097/00003226-199211030-00007Open DOISearch in Google Scholar

23. Felt O, Gumy R. Delivery of Antibiotics to the Eye Using a Positively Charged Polysaccharide as Vehicle. AAPS PharmSci. 2001; 3:1-7.10.1208/ps030434Open DOISearch in Google Scholar

24. A PK/PD Approach to Antibiotic Therapy page. Available at: http://www.rxkinetics.com/antibiotic_pk_pd.html. Accessed on February 8, 2009.Search in Google Scholar

25. Bendtzen K, Diamant M, Faber V. Fusidic acid, an immunosuppressive drug with functions similar to cyclosporine A. Cytokine. 1990; 2:423-9. 10.1016/1043-4666(90)90051-TOpen DOISearch in Google Scholar